80,000 Hours Podcast cover image

Rob Wiblin on self-improvement and research ethics

80,000 Hours Podcast

00:00

Rethinking FDA Regulations

This chapter explores the need for enhanced FDA regulations regarding medical treatments, advocating for clearer labeling and better reporting on non-approved drugs. It argues for a balance between patient autonomy and safety, emphasizing informed consent and the complexities of drug evaluation processes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app